IRENE ABRAMOVICH: Open Payments
NPI 1407864887 · WEST HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$45,883 in 105 payments from 7 companies in 2025. Trend: 2023 $69,627 · 2024 $84,128 · 2025 $45,883
Honoraria: $20,100Speaker / faculty: $13,323Consulting: $8,395Travel & lodging: $2,266Food & beverage: $1,799
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 18 | $14,680 |
| Axsome Therapeutics, Inc. | 8 | $12,418 |
| Supernus Pharmaceuticals, Inc. | 9 | $9,022 |
| Teva Pharmaceuticals USA, Inc. | 11 | $8,694 |
| Otsuka America Pharmaceutical, Inc. | 10 | $506 |
| ABBVIE INC. | 35 | $378 |
| Lundbeck LLC | 14 | $184 |
Products named: Auvelity, Qelbree, UZEDY, COBENFY, REXULTI, VRAYLAR.
Industry payments across CT — which companies pay providers there.
